Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2 Myeloid 2 Gastrointestinal 2 Tumor-Agnostic 1 Thoracic 1 Other hematologic neoplasm 1 Head & Neck 1 Dermatologic 1 CNS 1

Conditions

Head and Neck Neoplasms 16 Mouth Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 4 Laryngeal Neoplasms 4 Hypopharyngeal Neoplasms 4 Tongue Neoplasms 2 Salivary Gland Neoplasms 2 Paranasal Sinus Neoplasms 2 Nasopharyngeal Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma 2 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Stomatitis 1 Recurrence 1 Precancerous Conditions 1 Pharyngeal Neoplasms 1 Papilloma 1 Neoplasms 1 Mucositis 1 Leukoplakia, Oral 1 Laryngeal papillomatosis 1 Adenocarcinoma, Follicular 1

Interventions

pembrolizumab 33 Cetuximab 16 Cisplatin 10 Radiotherapy 8 Paclitaxel 8 Docetaxel 8 atezolizumab 7 Fluorouracil 7 cemiplimab 6 Drug Therapy 6 budigalimab 5 Gemcitabine 5 Cyclophosphamide 5 Blood Specimen Collection 5 trametinib 4 Pemetrexed 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 Bleomycin 4 Bevacizumab 4 palbociclib 3 fludarabine 3 durvalumab 3 dabrafenib 3 avelumab 3 Trastuzumab 3 Oxaliplatin 3 Interleukin-2 3 Indocyanine Green 3 Immunotherapy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Celecoxib × Head & Neck × Clear all

NCT00581971 2013-04-25

RAD0201

University of Alabama at Birmingham

Phase 1/2 Completed

30 enrolled 8 charts

Head and Neck Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡